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The group 1 metabotropic glutamate receptors 1 and 5 (mGluR1/5) have been implicated in
mechanisms of synaptic plasticity andmay serve as potential therapeutic targets in autism spec-
trum disorders. The interactome of group 1 mGluRs has remained largely unresolved. Using a
knockout-controlled interaction proteomics strategy we examined themGluR5 protein complex
in two brain regions, hippocampus and cortex, and identifiedmGluR1 as its major interactor in
addition to the well described Homer proteins. We confirmed the presence of mGluR1/5 com-
plex by (i) reverse immunoprecipitation using an mGluR1 antibody to pulldownmGluR5 from
hippocampal tissue, (ii) coexpression in HEK293 cells followed by coimmunoprecipitation to
reveal the direct interaction of mGluR1 and 5, and (iii) superresolution microscopy imaging of
hippocampal primary neurons to show colocalization of the mGluR1/5 in the synapse.
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1 Introduction
Group1 metabotropic glutamate receptors are G-protein
coupled receptors comprising the closely related mGluR1
(GRM1) and 5 (GRM5), where mGluR1 exists in two iso-
forms differing only at the C-termini due to alternative splic-
ing of the gene [1]. Metabotropic GluR5 is primarily local-
ized at the postsynapse, where it regulates short- and long-
term synaptic plasticity, in particular long-term depression
[2]. Activation of metabotropic glutamate receptor 1 and 5
(mGluR1/5) leads via Gq/G11 proteins to the initiation of
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phospholipase-C thereby eliciting IP3 and diacylglycerol
signaling [3]. In addition, mGluR1/5 activation can lead to
the activation of MAPK/ERK and MTOR/p70 S6 kinase,
which are involved in synaptic plasticity [3, 4]. Nonsynap-
tic mGluR5 also exists, and was recently shown to activate
different signaling systems than synaptic mGluRs [5]. Neg-
ative or positive allosteric modulators of mGluR5 have ther-
apeutic potential for a number of brain disorders including
fragile X mental retardation and schizophrenia [6]. Accord-
ingly, mGluR5 is considered a promising drug target aimed
at alleviating various neurological and psychiatrically disor-
ders by pharmacological intervention of the receptor activity
[3, 7, 8].
Besides G-proteins, also phosphatases (PP11) [9], kinases
(PKC) [10], scaffoldingproteins (NHERF-2, Tamalin/GRASP)
[11, 12], and ion channels (Grid2) [13], have been reported
as being part of the group1 mGluR signaling complexes,
and driving diverse cellular processes, such as, subcellu-
lar localization and Ca2+ responses presumably in a brain
region specific manner. mGluR5 is abundantly present in
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Significance of the study
Interaction proteomics has the potential to identify protein
interactions that take part in the formation of multicom-
ponent complexes. For the first time, we used a knockout-
controlled interaction proteomics strategy to investigate the
mGluR5 interactome directly from the hippocampus and the
cortex and found that constituents of the mGluR5 complex
are similar between the cortex and the hippocampus. We
show that a population of mGluR5 forms a stable complex
withmGluR1 in both brain regions. These findings have im-
plications in the design and study of allosteric modulators of
heteromeric receptor complexes and the understanding of
the role of these receptors and their modulators in vivo. Fur-
thermore, the immunoprecipitation protocol combined with
a filter-aided sample preparation protocol paves the way for
large-scale high-content interaction proteomics studies for
other protein receptor complexes in the brain.
the hippocampus and mGluR1 has a higher expression in
cerebellum [14]. As functions of mGluRs critically depend
on their interacting proteins, it is important to elucidate the
constituents of these protein complexes. Attempts have been
made to elucidate the mGluR1/5 interactome, but with vari-
able success due to the use of only an in vitro model and/or
ambiguity of some interactors [15, 16].
In the present study, we used a knockout-controlled in-
teraction proteomics analysis to examine the interactome
of mGluR5 in hippocampus and cortex. Apart from the
known interacting proteins, Homer1-3, two mGluR1 iso-
forms, mGluR1a and 1b, form a complex with mGluR5. We
confirmed the presence of the mGluR5-1a/b complex in hip-
pocampus by reverse immunoprecipitation (IP), revealed the
direct interaction of mGluR1/5 by coimmunoprecipitation
from HEK293 cells coexpressing both receptors, and demon-
strated the colocalization of mGluR1/5 at the postsynapse
by structured illumination superresolutionmicroscopy (SIM)
imaging.
2 Materials and methods
2.1 Sample preparation and IP
Whole hippocampus and cortex were dissected from mouse
brains, and stored at −80C until used. The brain issue was
homogenized in 1% freshly preparedn-dodecyl-D-maltoside
containing 25 mM HEPES (pH 7.4) and 150 mM NaCl and
a protease inhibitor cocktail (Roche), in a PotterS homoge-
nizer with 12 strokes at 900 rpm and incubated for 1 h at
4C. After centrifugation at 20 000 × g for 20 min the su-
pernatant was collected and centrifuged again at 20 000 × g
for 20 min. The final supernatant was used for IP, with the
equivalent of one hippocampus and 0.3 cortex per IP experi-
ment. Tenmicrograms of antibodywas added to each sample,
and incubated overnight at 4C with rotation. Sixty micro-
liters Protein A/G plus agarose bead (Santa Cruz) was used
per IP to capture the antibody. After washing, the agarose
beads containing the protein complex were subjected to filter-
aided sample preparation (FASP) treatment (as described
below).
The anti-mGluR5 polyclonal antibody was obtained from
Genscript (A01493); the anti-mGluR1a monoclonal antibody
was obtained from BD Biosciences (clone G209-488). These
antibodies were also used for immunoblot analysis and im-
munostaining of primary neurons.
2.2 FASP in-solution digestion of proteins
FASP was used with small modifications [17]. In short,
agarose beads from an IP experiment were gently vortexed in
75 L 2% SDS, 1 L 50 mM Tris (2-carboxyethyl)phosphine
at 55C for 1 h. The reduced cysteines were blocked by in-
cubation with 0.5 L 200 mM methyl methanethiosulfonate
for 15 min at RT. The sample was centrifuged at 16 000
× g for 20 min. The supernatant was mixed with 200 L
8 M Urea in Tris pH 8.8, transferred to Microcon-30 (Mil-
lipore, Lot R4NA17256), and centrifuged at 14 000 × g for
12 min at RT. The addition of 200 L 8 M urea to the fil-
ter and centrifugation were repeated three times. To remove
urea, four serial washes were performed with the addition of
200L 50mMNH4HCO3 for each wash followed by centrifu-
gation as stated above. Samples were digested with 0.7 g
Trypsin/Lys-C Mix (MS grade from Promega) in 100 L
50 mM NH4HCO3 overnight in a humidified chamber at
37C. Hundred microliters of 0.1% acetic acid was added
to the filter, and centrifuged. The tryptic peptides were col-
lected, dried in a speedvac, and stored at −20C until LC–MS
analysis.
2.3 Preparation of P1, P2, and microsome fractions
P1, P2, and Microsome fractions were prepared as in [18].
Briefly, hippocampi were homogenized in ice-cold homog-
enization buffer (0.32 M sucrose, 5 mM HEPES (pH 7.4))
containing protease inhibitor (Roche). Pellet 1 (P1) was
obtained after spinning at 1000 × g at 4C for 10 min.
The supernatant was spun at 20 000 x g at 4C to obtain
Pellet 2 (P2). The supernatant from P2 was further cen-
trifuged at 100 000 × g for 2 h to obtain a microsome
fraction.
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2.4 In-gel separation digestion of proteins
IPs were performed as before on an equal amount (2 mg) of
P2, microsome, and P1 fractions from hippocampus. SDS-
PAGE electrophoresis and in-gel digestion were performed
as described [19].
2.5 LC–MS/MS acquisition and data analysis
Peptides were analyzed by two types of nano-LC MS sys-
tems, namely LTQ-Orbitrap Discovery (Thermo Scientific)
and TripleTOF 5600+ (Sciex) MS. For the analysis using
TripleTOF 5600+ MS, it was coupled with an Ultimate
3000 LC system (Dionex, Thermo Scientific). Peptides were
trapped on a 5mmPepmap 100C18 column (300mid, 5m
particle size, Dionex) and fractionated on a 200 mm Alltima
C18 column (100 m id, 3 m particle size). ACN concentra-
tion in the mobile phase in 0.1% formic acid was increased
from 5 to 18% in 88 min, to 25% at 98 min, 40% at 108 min,
and to 90% at 110 min, at a flow rate of 400 nL/min. Peptides
were electrosprayed into the mass spectrometer using an ion
spray voltage of 2.5 kV, curtain gas at 35 p.s.i., nebulizer gas
at 15 p.s.i., and an interface heater temperature of 150C.
The MS survey scan range was m/z 350–1250 acquired for
250ms. The top 20 precursor ions were selected for 85ms per
MS/MS acquisition, with a threshold of 90 counts. Dynamic
exclusion was 16 s. Rolling CID function was activated, with
an energy spread of 15 eV.
For the analysis using the LTQ-OrbitrapMS, peptides were
loaded onto a nano-LC Ultra system (Eksigent) with the trap-
ping and separation columns as described for 5600+ MS
analysis. ACN concentration in 0.1% acetic acid was linearly
increased from 5 to 40% in 80 min and to 90% in 10 min,
and electro-sprayed into the LTQ-Orbitrap MS using an ion
spray voltage of 1.4 kV and heater temperature of 200C.
LTQ-Orbitrap was operated in the range of m/z 350–2000 at
a FWHM resolution of 30 000 after accumulation to 500 000
in the LTQ with one microscan. The five most abundant pre-
cursor ions were selected for fragmentation by CID with an
isolation width of 2 Da.
All raw MS data were analyzed by MaxQuant software
(version 1.5.2.8) with search engine Andromeda. The Mouse
database used was UniProt_2015-02. The fixed modification
was MMTS (for FASP) and propioamide (for in-gel digestion
samples). Match between runs with match time window of
0.7 min and alignment time window of 5 min were used for
all analyses. For other parameters the default settings were
used.
2.6 Expression plasmids
Mouse mGluR1, transcript variant 1 (NM_016976.3), was
Gateway-cloned into the pReceiver-Lv186 vector, yielding
mGluR1-pReceiver-Lv186 (including a C-terminal 3xHA-tag)
(GeneCopoeia; catalog number EX-Mm02865-Lv186). Mouse
mGluR5, transcript variant a (NM_001081414), was cloned
into the pcDNA3.1(+) vector, yielding mGluR5-pcDNA3.1
(Genscript).
2.7 HEK293 cell culture and transfection
HEK293 cells (ATCC) were cultured in DMEM medium
(Gibco, Life Technologies), 10% FBS (Invitrogen), and 1%
penicillin-streptomycin (Gibco, Life Technologies) in 10 cm
dishes. Cells were 60–70% confluent at the time of transfec-
tion and of passage number 14. Medium was refreshed 2–
3 h prior to transfection. HEK293 cells were transfected with
plasmid DNA (5 g) using polyethylenimine (25 kDa linear,
Polysciences) and incubated for 48 h after transfection.
2.8 Coprecipitation from HEK293 cells
All steps were performed at 4C, with the exception of elu-
tion (room temperature). For protein extraction,HEK293 cells
werewashedwith PBS, resuspended in freshly prepared lysis-
buffer (1% DDM, 25 mM HEPES (pH 7.4), 150 mM NaCl,
and EDTA-free Complete protease inhibitor (Roche)), and in-
cubated for 1 h with gentle end-over-end mixing. The super-
natant was cleared of nonsoluble debris by two consecutive
centrifugation steps at 20 000 × g for 15 min. Anti-mGluR1
antibody (4 ug) or anti-mGluR5 antibody (4 ug) was added to
the supernatant, incubated O/N, and immobilized to Protein
A/G agarose beads (Santa Cruz). The agarose beads were
washed four times with wash buffer (0.1% DDM, 25 mM
HEPES, and 150 mM NaCl), and the bound proteins were
eluted by incubation with 2× Laemmli sample buffer. Input
samples were prepared from the supernatant fraction by ad-
dition of Laemmli sample buffer to a 2× final concentration.
2.9 SDS-PAGE and immunoblot analysis
Protein samples were heated to 55C for 45 min prior to
loading onto a 4–15% Criterion TGX Stain-Free Precast gel
(Bio-Rad), with the input samples representing 3% of the
lysate used for IP. The gel-separated proteins were imaged
with the Gel-Doc EZ system (Bio-Rad), directly transferred
onto Immun-Blot PVDF membrane (Bio-Rad) and probed
O/N at 4C with mGluR1 antibody (1:1000) or mGluR5 anti-
body (1:1000). Chemiluminescence scans were acquired with
the Odyssey Fc system (Li-Cor), and analyzed using Image
Studio Lite 5.2.5 software (Li-Cor).
2.10 Protein molecular weight prediction
The predicted molecular weight was determined using the
Expasy online tool (http://web.expasy.org/compute_pi/). The
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Table 1. Intensities of mGluR5 interactors immunoprecipitated from cortex and hippocampus
Gene Names CORTEX HIPPOCAMPUS
KO-1 KO-2 KO-3 KO-4 WT-1 WT-2 WT-3 WT-4 KO-1 KO-2 KO-3 KO-4 WT-1 WT-2 WT-3 WT-4
Grm5 4 × 106 1 × 106 — — 2 × 109 2 × 109 1 × 109 2 × 109 — — — 1 × 106 1 × 109 2 × 109 1 × 109 1 × 109
Homer1 — — — — 3 × 108 2 × 108 1 × 108 1 × 108 — — — — 5 × 107 1 × 108 1 × 108 1 × 108
Grm1
(isoform b)
— — — — 2 × 107 2 × 107 2 × 107 3 × 107 — — — — 1 × 107 4 × 107 2 × 107 1 × 107
Homer3 — — — — — — — — — — — — 4 × 106 2 × 106 1 × 107 1 × 107
Homer2 — — — — 3 × 106 7 × 106 6 × 106 3 × 106 — — — — 6 × 106 3 × 106 1 × 107 8 × 106
Grm1
(isoform a)
— — — — 4 × 106 7 × 106 4 × 106 3 × 106 — — — — 2 × 106 1 × 107 4 × 106 4 × 106
Grm3 — — — — 1 × 106 — 1 × 106 1 × 106 — — — — — — — 5 × 105
Clu — — — — 3 × 106 2 × 106 1 × 106 3 × 106 — — — — 2 × 106 2 × 106 2 × 106 —
Rab3gap1 — — — — 6 × 108 6 × 108 8 × 108 9 × 108 — 8 × 108 8 × 108 — — 7 × 108 — —
Atp1a2 — — 7 × 105 1 × 106 — — 8 × 105 1 × 106 — — — — 2 × 106 — 3 × 106 2 × 106
Hbbt1;
Hbb-bs
— — — — 6 × 106 3 × 106 7 × 106 6 × 106 5 × 106 — 1 × 106 — 5 × 107 4 × 106 1 × 107 2 × 107
Slc3a2 — — – — — — 7 × 105 6 × 105 — — — – 2 × 106 — 1 × 106 3 × 106
Glud1 — — — — — — — — — — — — 2 × 106 — 2 × 106 2 × 106
Atp6v1e1 — — — — — — — — — — — — 2 × 106 — 2 × 106 1 × 106
Maxquant MS1 peak intensities for the proteins quantified for unique peptides obtained from the mGluR5 IPs are listed here. Proteins are
at least tenfold enriched in WT, and observed at least three of four times in WT. Gene names in italic are present in empty beads experiment
in Table 2, and most likely represent false positives.
KO: mGluR5 IP from knockout mice; WT: mGluR5 IP from wild-type mice.
predicted molecular weight for mGluR1 as expressed by the
mGluR1-pReceiver-Lv186 plasmid (including a C-terminal
3xHA-tag) was 137.6 kDa. The predicted weight for mGluR5
was 128.3 kDa.
2.11 Immunostaining of primary neurons
Primary hippocampal neurons were obtained from E18 rat
pups. Briefly, 18 000 cells were grown in neurobasal medium
supplemented with B27 on poly D-Lysine coated coverslips.
The cells were used for staining at DIV 14–16. The coverslips
were fixed with ice-cold methanol for 10 min, followed by
three washes in ddH2O and PBS. The neurons were then
blocked and permeablized with blocking buffer (5% FCS,
0.1% Triton X-100, and 0.1% glycine in phosphate buffer
saline) for 1 h. Next, the neurons were incubated with anti-
mGluR1 or anti-mGluR5 antibodies, and anti-Homer1 (cat.
no. 160 004, Synaptic systems), diluted in blocking buffer
overnight at 4C. After washing three times in PBS, the cells
were incubated with an alexa conjugated secondary antibody
for 1 h at room temperature (anti-rabbit Alexa 488 (1 in 1000),
anti-mouse Alexa 568 (1 in 1000), anti-Guinea pig Alexa 647
(1 in 1000) (Molecular Probes) and subsequently washed and
fixed on glass slides (Superfrost Plus, Thermo) using Moviol.
Images were taken using a Zeiss Elyra PS1 SIM microscope
with 63× oil immersion lens (N.A. 1.4) and reconstructed
images were analyzed using ImageJ.
3 Results and discussion
In the present study, we employed interaction proteomics to
reveal the mGluR5 interactome. Generally, antibody-based
interaction proteomics experiments are noisy, i.e. they are
populated by consistently present background protein con-
taminants as well as by a large number of proteins that ap-
pear sporadically in the individual IPs. Here, we used an
mGluR5 knockout mouse as a negative control to remove
false positives, which in addition should address the problem
of (potential) cross-reactivity of the antibody. We carried out
multiple IP replicates to filter out the sporadically occurring
proteins. As we focused on stable mGluR complexes, the pro-
tein constituents of the complexes should be present inmost,
if not all, IPs. We took a stringent filter to select interacting
proteins, whichmust be present in3 of 4 IPs fromWT sam-
ples and have an enrichment factor of10-fold. From the ap-
proximately 300 identified proteins in the mGluR5 IPs from
extracts of hippocampus and cortex (excluding external con-
taminants, such as keratins, antibodies, trypsin, and bovine
proteins), 14 proteins pass this filter (Table 1). The bait pro-
tein mGluR5 has the highest intensity, followed by Homer1
and mGluR1. mGluR1 is present at a much lower amount
than mGluR5, suggesting that a fraction of mGluR5 protein
complexes containmGluR1. Proteins of lower intensity in the
IP tablemostly represent high abundant proteins in the origi-
nal extract materials, notablymitochondrial proteins and pro-
teins involved in energy metabolism, both of which are often
considered as themajor sources of contaminants in typical IP
experiments. In case a protein passed the filter in one brain
region (for example Rab3gap1 and Atp1a2) but was detected
in KO samples from another brain region at a level of those
of WT, they may present false positives and therefore should
be considered with caution (see also Table 2). The present,
as well as our previous studies, identified 200–300 proteins
from a single IP. To reveal true positives, stringent filter(s)
were applied, together with the use of negative control(s),
such as the appropriate knockout mouse samples or alterna-
tively the antigen peptide blocking approach. Furthermore,
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Table 2. Intensities of mGluR5 interactors immunoprecipitated from hippocampal subfractions
Gene Names Microsome P1 P2
EB IP_1 IP_2 EB IP_1 IP_2 EB IP_1 IP_2
Grm5 — 4 × 108 3 × 108 — 3 × 108 3 × 108 — 2 × 108 2 × 108
Grm1 (isoform a) — 490 210 444 620 — 330 400 391 060 — 262 450 162 310
Grm1 (isoform b) — — 852 620 — 825 770 828 400 — 300 820 694 750
Homer1 — 7 × 106 1 × 107 — 8 × 106 1 × 107 — 8 × 106 7 × 106
Homer3 — 526 800 606 300 — 2 × 106 2 × 106 — 2 × 106 2 × 106
Atp6v1e1 425 540 693 690 482 760 247 240 — — 297 740 461 910 366 990
Glud1 305 810 349 040 — — — — 623 670 — 371 350
Hbbt1; Hbb-bs 2 × 106 2 × 106 589 360 2 × 106 2 × 106 2 × 106 3 × 106 1 × 106 —
Slc3a2 — — — 174 410 — — 157 460 — —
Maxquant MS1 peak intensities for the proteins quantified for unique peptides obtained from the mGluR5 IPs are listed here. Proteins in
italic are the putative mGluR5 interactors shown in Table 1. They are present in the empty bead controls and most likely represent false
positives.
EB: Empty bead control; P1: Pellet 1; P2: Pellet 2.
Table 3. mGluR1a IP from hippocampus confirms the mGluR1-5
interaction
Gene names HIPPOCAMPUS
Ig-1 Ig-2 BD-1 BD-2
Grm1 (isoform a) — — 29 026 52 842
Grm1 (isoform b) — — 4388.1 3858.6
Grm5 — — 2044.3 10 978
Homer3 — — 10 924 6548.8
Maxquant MS1 peak intensities for the proteins quantified for
unique peptides obtained from the mGluR1 IPs are listed here.
BD: IP performed with mGluR1a antibody from BD Biosciences;
Ig: IP performed with non-mGluR1 antibody as negative control.
reverse IP was used to confirm the interaction [19]. In this
context, a recent interaction proteomics study highlighted a
similar example in which 495 proteins were identified from
an IP, which eventually was filtered to 16 interactors [20].
Recently, using the same strategy we examined the interac-
tome of an adhesion molecule, Caspr2 (CNNTP2), and re-
vealed tens of proteins as genuine interactors [21]. Here, we
revealed a simple composition of mGluR5 interactome with
Homer1, 2, and 3 and mGluR1a/b as main interactors. This
interactome is simple in contrast to, for instance, the complex
interactome of the ionotropic AMPA-type glutamate recep-
tors, which is reported to contain up to 30 associated proteins
[22–24]. A G-protein coupled receptor, such as mGluR5, may
exhibitmany transient interactions during its activation as ex-
emplified by the interaction with G-protein subunits. These
short-lived interactions of presumably relatively low affinity
may not be recovered in IP. This might explain that only a
small but stable mGluR5 interactome is revealed under the
present experimental conditions.
Homer 1, 2, and 3 were previously described as mGluR5
interactors, and indeed were recovered from our IPs at high
scores (>108). Homer 1, 2, and 3 of the homer family, exhib-
ited a distinct brain region-specific mGluR5 interaction pat-
tern, which closely reflects their differential gene expression
patterns in these brain regions. In particular, Homer 1 and
2 are abundantly expressed in cortex and hippocampus,
whereas Homer 3 is higher expressed in hippocampus but
low in cortex. It is of notice that differential spatial expression
occurs even within a brain region; in hippocampus Homer
1 and 2 show major expression in the CA1 region, whereas
Homer 3 has highest expression inCA3 (see AllenBrainAtlas
Mouse Brain ISH for Homer 1, 2, 3). Future studies will be
needed to resolve these protein complexes in order to reveal
their similarity/differences.
Although mGluR5 is abundantly present in the postsy-
napse, it is also found extrasynaptically in endoplasmic retic-
ulum as well as in astrocytes [25]. The activation of intracel-
lular dendritic pool of mGluR5 can mediate Ca2+ responses
in dendrites and are sufficient for mediating LTD in hip-
pocampal neurons [26]. To examine if there is difference of
mGluR5 protein complexes present in distinct subcellular
structures, we performed IP on biochemically fractionated
hippocampal subfractions, namely the P1 fraction enriched
in cell bodies, the synapse-enriched P2 fraction, and the mi-
crosome fraction that is enriched for endoplasmic reticulum,
Golgi, and vesicles [27]. The mGluR5 complex composition
was similar across different fractions (Table 2). It will be
interesting to explore the subcellular localization ofmGluR5–
Homer complex, which might be present outside the post-
synapse and thereby confirm the biochemical fractionation
data. Specific interactions may underlie distinct functions,
such as receptor trafficking or receptor-regulating roles. The
role of Homer1 in stabilization of mGluR5 scaffolds has
been well documented, however the functional implications
of mGluR1-mGluR5 complexes have not been studied in
muchdetail. Several potential interacting proteinswere found
(Table 1). Glud1, Atp6ve1, hemoglobin, and Scl3a2 were
found in empty bead controls in this experiment (Table 2),
and/or not consistently observed in mGluR5 IPs and there-
fore likely are false positives. The proteomics Maxquant out-
put files for all the IP experiments are shown in Supporting
Information Tables 1–3.
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In this study, we identified two isoforms of mGluR1 in
the mGluR5 IPs from cortex and hippocampus extracts.
mGluR1a and 1b are generated by alternative splicing and
differ at the C-termini; mGluR1b differs from 1a at residue
number 887–906 with the substitution of peptide sequence
NSNGKSVSWSEPGGRQAPKG of mGluR1a to KKRQPEF-
SPSSQCPSAHVQL, and the remaining amino acid sequence
(residues 907–1199) in mGluR1a is missing. As a conse-
quence there is only one unique (tryptic) peptide RQPEF-
SPSSQCPSAHVQL (Supporting Information Fig. 1) for 1b
isoform, compared to multiple unique peptides for 1a iso-
form.
To confirm themGluR1-5 interaction specific protein com-
plex, we used a monoclonal anti-mGluR1a antibody for IPs.
Several proteins were present in bothmGluR1a IPswith>10-
fold enrichment compared to the negative controls (Table 3).
In hippocampus, themGluR1a complex containedmGluR1b,
mGluR5, and Homer3. These observations are in general
agreement with the results of mGluR5 IPs. Homer 1 and 2,
that were abundantly present in hippocampal mGluR5 IPs,
were not detected in mGluR1a IP in the hippocampus. To-
gether, this indicates that (i) mGluR1-specific protein com-
plex harbors primarily Homer 3, and (2) heterodimerization
of mGluR1a-b and mGluR5 can exist in neurons.
To examine whether mGluR1-5 interact directly, we per-
formed co-IP experiments with expression ofmGluR1 and/or
5 in HEK293 cells (Fig. 1). We confirmed the direct interac-
tion of mGluR1/5 in the double expression of mGluR1 and
Figure 1. mGluR1 coimmunoprecipitateswithmGluR5 inHEK293
cells. Upper panel: mGluR1 was expressed in the presence or
absence of mGluR5 in HEK293 cells. Immunoprecipitation (IP)
using an mGluR5-specific antibody, and subsequent immunoblot
analysis, revealed the specific coprecipitation of mGluR1 with
mGluR5. Lower panel: Reverse conditions; expression of mGluR5
in the presence or absence of mGluR1, followed by mGluR1 IP,
confirmed the specific coprecipitation of mGluR5 with mGluR1.
Figure 2. Superresolution imaging validation of mGluR1-5 colocalization. SIM imaging in cultured hippocampal neurons at DIV 19 showing
an overview or zoom-ins of dendrites (right) or spines (right, inset). mGluR1 (green), mGluR5 (red) and, Homer1 (blue, synaptic marker)
are shown. Merge shows color-overlay images of the three channels. Scale bars are indicated. Merge panel: open arrows indicate non
synaptic overlap between mGluR1 and 5, closed arrows indicate synapses positive for mGluR1 and 5. Note that extrasynaptically a large
part of the mGluR1 is not colocalized with mGluR5.
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5, in which the IP of mGluR5 precipitated mGluR1 and the
IP of mGluR1 precipitated mGluR5. We further confirmed
the antibodies specificity; anti-mGluR1 antibody did not stain
mGluR5 and did not precipitate mGluR5, and vice versa anti-
mGluR5 antibody did not stain mGluR1 and did not precipi-
tate mGluR1.
If mGluR1 and 5 form a heteromeric complex, they should
colocalize in the cell. We performed coimmunostaining of
mGluR1 and 5 on hippocampal primary neurons and vi-
sualized these proteins with SIM imaging. The mGluR1, 5
colocalization was observed in synapses as indicated by their
colocalization with the postsynapse marker protein Homer,
and was also detected outside synapses (Fig. 2). There was
also mGluR5 that did not colocalize with mGluR1. Together,
these imaging data are supportive to our interaction pro-
teomics data that mGluR1/5 protein complex exists, and that
this complex constitutes a subpopulation of synapticmGluR5
(Table 1).
4 Concluding remarks
Although we demonstrated for the first time the presence
of mGluR1-5 protein complex in the brain, interaction of
mGluR1 and 5has been implicated previously. Chemical LTD
induced by selectivemGluR5 agonist DHPGwas abolished in
mGluR5 knockoutmouse [28]. However, in hippocampus the
complete blockade of chemical LTD required the combination
of both mGluR1 and five receptor antagonists [29], suggest-
ing heterodimerization of the two receptors. Time-resolved
fluorescence resonance energy transfer with the cell-surface
labeling of tagged rat mGluR subunits expressed in a mam-
malian cell line revealed that group II and III mGluR sub-
units can produce intergroup heteromeric receptors that are
functional, whereas group I mGluR subunits, i.e. mGluR1
and 5, can interact but do not associate with groups II and
III mGluR subunits [30]. Recently, mGluR2/4 heterodimers
have been found in the striatum at the corticostriatal synapse,
and exhibit a distinct pharmacological profile [31]. Functional
interdependence of mGluR1 homodimer and mGluR5 ho-
modimer has been indicated in sympathetic rat neurons co-
expressing both receptors [32]. This study also provides evi-
dence of two pools ofmGluR5 in striatal neurons, one of them
probably interacting with mGluR1. The discovery of mGluR
heteromerization represents a new avenue for the study of
mGluR pharmacology and neurobiology, of which the in vivo
consequences remain to be investigated.
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